Pulmonary Function and Arterial Stiffness in Chronic Heart Failure. (21st December 2016)

• Record Type: Journal Article
• Authors: Li, Li; Hu, Bangchuan; Gong, Shijin; Yu, Yihua; Dai, Haiwen; Yan, Jing
• Other Names: Montecucco Fabrizio Academic Editor.
• Is Part Of: BioMed research international. Volume 2016(2016)
• Publication Date: 2016-12-21
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Life sciences -- Periodicals; 610.5
• DOI: 10.1155/2016/5478394
• Languages: English
• ISSNs: 2314-6133

Abstract

Abstract : Arterial stiffness contributes to heart failure and is decreased by angiotensin receptor blockers (ARBs). This cross-sectional study aimed to assess associations of lung function and ARB with arterial stiffness in patients with chronic heart failure. 354 outpatients (168 males; 186 females; 68.2 ± 7.2 years old) with chronic heart failure were evaluated. Lung function parameters, including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1 ), and FEV1 to FVC ratio (FEV1 /FVC), were assessed. The cardio-ankle vascular index (CAVI) was used to estimate arterial stiffness. Unadjusted correlation analyses revealed a positive association of CAVI with ARB but not ACEI, and a negative correlation with FEV1 (r = - 0.2987, p < 0.0001 ). Multiple stepwise regression analyses showed that ARB and FEV1 (p < 0.0001 ) were independent predicting factors for CAVI. These findings suggest that reduced pulmonary function is associated with increased CAVI. Pulmonary function protection could be used to improve the prognosis in heart failure, but additional studies are necessary.